GWQ-59185-42741
4 vaccinations
4 coded responses
37 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 600 / IL
- Registered
- 2021-03-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
RC2-13948-74524
Child or adolescent in my care · Female · 2022-06-23
JH9-33650-08555
Child or adolescent in my care · Male · 2022-11-12
Timeline
-
2021-02-18
Dose 1 — Pfizer-BioNTech
-
2021-03-11
Dose 2 — Pfizer-BioNTech
-
2021-03-14
Registered in v-safe
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-06-10
- 2021-09-09
-
2021-10-02
Dose 3 — Pfizer-BioNTech
- 2021-10-02
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-11-01
- 2021-11-06
- 2021-11-13
- 2022-01-01
-
2022-04-02
Survey response — 6 months, dose 3MedDRA: Cough, Headache, Nasopharyngitis, Rhinorrhoea — Feeling: FairFree text: Cold symptoms (cough, runny nose, headache)MedDRA releases: 2024-11 · check-in free text available
-
2022-09-04
Dose 4 — Moderna
- 2022-09-05
- 2022-09-06
- 2022-09-08
-
2022-09-10
Survey response — days 1–6 daily, dose 4MedDRA: Upper-airway cough syndrome — Feeling: FairFree text: Post nasal dripMedDRA releases: 2024-11 · check-in free text available
-
2022-09-11
Survey response — day 7, dose 4MedDRA: Upper-airway cough syndrome — Feeling: Fair · Chills, Muscle or body aches, Fatigue or tirednessFree text: Post nasal dripMedDRA releases: 2024-11 · check-in free text available
- 2022-09-18
-
2022-09-25
Survey response — day 21, dose 4MedDRA: Cough, Throat irritation, Upper-airway cough syndrome — Feeling: GoodFree text: Itchy throat, post nasal drip, dry coughMedDRA releases: 2024-11 · check-in free text available
- 2022-10-02
- 2022-10-09
- 2022-10-16
- 2022-12-04
- 2023-03-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-18 | Pfizer-BioNTech | |
| 2 | 2021-03-11 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
| 4 | 2022-09-04 | Moderna | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: Cold symptoms (cough, runny nose, headache)
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Post nasal drip
Release 12 — day 7, dose 4
Systemic reaction (other): Post nasal drip
Release 12 — day 21, dose 4
Symptoms: Itchy throat, post nasal drip, dry cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release